EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Immunomodulation of salivary gland function due to cancer therapy

Ana C Costa-da-Silva, Carlos U Villapudua, Matthew P Hoffman, Marit H Aure iD

Oral Diseases · 2025-09 · 31 (9) · 2680-2694

DOI: 10.1111/odi.14972 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Oral Diseases, online erschienen am 02.05.2024. Verfasst von Ana C Costa-da-Silva und 3 weiteren Autor:innen. Beteiligte Einrichtung: Oral Immunobiology Unit, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, Maryland, USA. Hauptthemen laut MEDLINE: Salivary Glands, Immunomodulation, Neoplasms, Salivary Gland Diseases. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 100 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Intramural NIH HHS, NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Functional salivary glands (SG) are essential for maintaining oral health, and salivary dysfunction is a persistent major clinical challenge. Several cancer therapies also have off‐target effects leading to SG dysfunction. Recent advances highlight the role of SG immune populations in homeostasis, dysfunction and gland regeneration. Here, we review what is known about SG immune populations during development and postnatal homeostasis. We summarize recent findings of immune cell involvement in SG dysfunction following cancer treatments such as irradiation (IR) for head and neck cancers, immune transplant leading to graft‐versus‐host‐disease (GVHD) and immune checkpoint inhibitor (ICI) treatment. The role of immune cells in SG in both homeostasis and disease, is an emerging field of research that may provide important clues to organ dysfunction and lead to novel therapeutic targets.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Salivary GlandsImmunomodulationNeoplasmsSalivary Gland DiseasesHumansImmune Checkpoint InhibitorsGraft vs Host DiseaseHead and Neck Neoplasms

Stichwörter der Autor:innen

GVHDcheckpoint inhibitor therapyirradiationregenerationsalivary glandsalivary hypofunctiontissue resident immune cells

Substanzen

Immune Checkpoint Inhibitors

Autor:innen und Institutionen

  • Oral Immunobiology Unit, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, Maryland, USA.
  • Matrix and Morphogenesis Section, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, Maryland, USA.

ORCID-Profile: Marit H Aure

Förderung

  • Intramural NIH HHS
  • NIH HHS
  • National Institutes of Health

Zitieren

APA

Costa-da-Silva, A. C., Villapudua, C. U., Hoffman, M. P., & Aure, M. H. (2025). Immunomodulation of salivary gland function due to cancer therapy. Oral Diseases, 31(9), 2680-2694. https://doi.org/10.1111/odi.14972

Vancouver

Costa-da-Silva AC, Villapudua CU, Hoffman MP, Aure MH. Immunomodulation of salivary gland function due to cancer therapy. Oral Diseases. 2025;31(9):2680-2694. doi:10.1111/odi.14972

BibTeX
@article{CostadaSilva2025,
  author = {Costa-da-Silva, Ana C and Villapudua, Carlos U and Hoffman, Matthew P and Aure, Marit H},
  title = {Immunomodulation of salivary gland function due to cancer therapy},
  journal = {Oral Diseases},
  year = {2025},
  volume = {31},
  number = {9},
  pages = {2680--2694},
  doi = {10.1111/odi.14972}
}
Kostenlos starten →